US2016279064A1PendingUtilityA1

Crosslinked Polysaccharide Beads and Their Biomedical Uses

Assignee: INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)Priority: Aug 31, 2010Filed: Jun 3, 2016Published: Sep 29, 2016
Est. expiryAug 31, 2030(~4.1 yrs left)· nominal 20-yr term from priority
A61P 35/00A61L 2430/20Y10T428/2982A61K 9/1652A61K 9/0019C08B 37/0018A61L 2430/06A61K 9/0024C08B 37/0021A61K 9/1075A61L 27/20A61K 47/26A61K 9/1682A61L 2430/02
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present inventions relates to beads as biocompatible material adapted for use within the human or animal body. Said beads are highly useful for tissue engineering, in situ tissue regeneration, as well as for drug and/or cells delivery. In addition, said beads may support biotechnological applications such as cell carriers.

Claims

exact text as granted — not AI-modified
1 - 9 . (canceled) 
     
     
         10 . A bead obtained by
 a) preparing an alkaline aqueous solution comprising at least one polysaccharide and a cross linking agent;   b) dispersing said alkaline aqueous solution into an hydrophobic phase in order to obtain a water-in-oil (w/o) emulsion; and   c) transforming the w/o emulsion into beads by placing said w/o emulsion at a temperature from about 4° C. to about 80° C. for a sufficient time to allow the cross-linking of said at least one polysaccharide;   
       wherein,
 said polysaccharide is selected from the group consisting of dextran, pullulan, agar, alginic acid, starch hyaluronic acid, inulin, heparin, fucoidan, chitosan and mixtures thereof. 
 
     
     
         11 . The bead according to  claim 10 , wherein said bead has a size of from 5 nm to 5 mm. 
     
     
         12 - 17 . (canceled)

Join the waitlist — get patent alerts

Track US2016279064A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.